Home » Topics » BioWorld Science, Biomarkers

BioWorld Science, Biomarkers
RSS

NPAS3 identified as a risk gene for autism spectrum disorder

Oct. 21, 2021

Whole exome sequencing analysis identifies novel genes associated with osteoarthritis

Oct. 21, 2021

Role of de novo mutations in severe male infertility

Oct. 21, 2021

LRFN1 gene as a possible cause of autism spectrum disorder

Oct. 21, 2021

Elevated plasma CXCL16 levels found in severe COVID-19 patients

Oct. 21, 2021

Missense mutation in the MMP14 gene causes autosomal dominant hypotrichosis

Oct. 20, 2021

NDEL1 gene may play a role in lissencephaly

Oct. 20, 2021

SNIP1 gene variant linked to neurodevelopmental disorder in Amish families

Oct. 20, 2021

Plasma and tissue FGL1 expression is increased in patients with Crohn's disease

Oct. 18, 2021

Antidepressant treatment modulates inflammatory cytokine plasma levels in major depression

Oct. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...